Victoria’s Semaphore Solutions has received a significant investment from Cypress Ridge Capital, a healthcare-focused growth equity firm.
Founded in 2010, Semaphore Solutions is a leading SaaS and informatics services company addressing inherent challenges in the paradigm shift to personalized medicine.
The new partnership will enable the company to accelerate investments in its highly innovative SaaS platform, strengthen relationships with industry partners, and expand its professional services offering.
“We are delighted to partner with Cypress Ridge to help support our next phase of growth,” said Peter Smith, Co-Founder and CEO of Semaphore.
“The laboratories we work with are facing challenges due to increasingly complex workflows, higher throughput, and massively scaled data processing. These challenges will intensify as the translation of scientific research into meaningful health outcomes accelerates.”
The company also announced the appointment of Cypress Ridge Platform Partner, Anthony Uzzo, to its Board of Directors. Mr. Uzzo previously co-founded Core Informatics and later served as VP of R&D, Digital Science at Thermo Fisher Scientific.
Photo: Semaphore’s website
Leave a Reply